BioStem Technologies Revenue and Competitors

BioStem Technologies, Inc. is a pre-clinical-stage biotechnology company focused on harnessing elements of Perinatal Tissue and the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases. Our proprietary approach, called Local MicroEnvironment Activation, or LMA, uses combinations of Small Molecules, Cytokines, and Growth Factors (“SMCGF”) to activate the microenvironment within the body to create communication for repair in the tissue. At BioStem Technologies, quality is top priority to us because we value patient safety above all else. In our AATB® accredited, FDA-registered, cGMP compliant lab, we strive to provide products and services which not only meet but exceed, Current Good Tissue Practice requirements. By developing novel approaches to industry-changing processes, we focus on better than status quo.